13 analysts have shared their evaluations of KeyCorp KEY during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 3 | 7 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 3 | 0 | 0 |
| 3M Ago | 1 | 1 | 3 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $17.58, a high estimate of $20.00, and a low estimate of $15.00. This upward trend is evident, with the current average reflecting a 4.58% increase from the previous average price target of $16.81.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of KeyCorp by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Chiaverini | Wedbush | Raises | Neutral | $18.00 | $17.00 |
| David Konrad | Keefe, Bruyette & Woods | Maintains | Outperform | $18.00 | $18.00 |
| Ken Usdin | Jefferies | Raises | Buy | $19.00 | $18.00 |
| Manan Gosalia | Morgan Stanley | Raises | Equal-Weight | $20.00 | $18.00 |
| Gerard Cassidy | RBC Capital | Maintains | Outperform | $17.00 | $17.00 |
| Keith Horowitz | Citigroup | Raises | Buy | $19.00 | $18.00 |
| David Chiaverini | Wedbush | Raises | Neutral | $17.00 | $16.00 |
| Manan Gosalia | Morgan Stanley | Raises | Equal-Weight | $18.00 | $16.00 |
| Robert Kwan | RBC Capital | Raises | Outperform | $17.00 | $16.00 |
| Peter Winter | DA Davidson | Raises | Buy | $18.00 | $16.00 |
| David Chiaverini | Wedbush | Raises | Neutral | $16.00 | $15.00 |
| Erika Najarian | UBS | Lowers | Neutral | $15.00 | $16.00 |
| Steven Alexopoulos | JP Morgan | Lowers | Neutral | $16.50 | $17.50 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to KeyCorp. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of KeyCorp compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into KeyCorp's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on KeyCorp analyst ratings.
All You Need to Know About KeyCorp
With assets of over $180 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
KeyCorp's Financial Performance
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Negative Revenue Trend: Examining KeyCorp's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -4.46% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 16.11%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): KeyCorp's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.96%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): KeyCorp's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.13%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: KeyCorp's debt-to-equity ratio surpasses industry norms, standing at 1.8. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
How Are Analyst Ratings Determined?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
